Paratek Pharma Inc
(PRTK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 12,616 | 29 | 0 | 4,342 | 478 |
| Gross Profit | 12,616 | 29 | N/A | 4,342 | 478 |
| Operating Expenses | 97,196 | 109,515 | 70,053 | 12,140 | 8,018 |
| Operating Income | -84,580 | -109,486 | -70,053 | -7,798 | -7,540 |
| Interest Expense | 5,079 | 3,223 | 770 | 718 | 294 |
| Other Income | 1,343 | 1,073 | -37 | -9,319 | 3,181 |
| Pre-tax Income | -88,316 | -111,636 | -70,860 | -17,835 | -4,653 |
| Income Tax | 753 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -89,069 | -111,636 | -70,860 | -17,835 | -4,653 |
| Net Income | $-89,069 | $-111,636 | $-70,860 | $-17,835 | $-4,653 |
| EPS Basic Total Ops | -3.32 | -5.51 | -4.29 | -7.82 | -185.13 |
| EPS Basic Continuous Ops | -3.32 | -5.51 | -4.29 | -7.05 | -75.05 |
| EPS Diluted Total Ops | -3.32 | -5.51 | -4.29 | -7.82 | -185.13 |
| EPS Diluted Continuous Ops | -3.32 | -5.51 | -4.29 | -7.05 | -75.05 |
| EPS Diluted Before Non-Recurring Items | -3.30 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-83,312 | $-107,183 | $-69,339 | $-7,602 | $-7,442 |